US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 107.190
  • +0.190+0.18%
Close May 3 16:00 ET
  • 108.908
  • +1.718+1.60%
Post 17:30 ET
6.71BMarket Cap-22238P/E (TTM)

Blueprint Medicines Key Stats

Blueprint Medicines Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

96.12M

+51.87%
EPS(YoY)

1.40

+165.12%

Buy

May 5, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 111.264M--
--2024/Q2-- / 102.355M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--
Aug 2, 20232023/Q257.570M / 45.603M--
May 4, 20232023/Q163.287M / 41.853M--
Feb 16, 20232022/Q438.781M / 33.521M--
--2022/Q365.977M / 43.876M--
Aug 2, 20222022/Q236.547M / 37.613M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 111.264M--
--2024/Q2-- / 102.355M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--
Aug 2, 20232023/Q257.570M / 45.603M--
May 4, 20232023/Q163.287M / 41.853M--
Feb 16, 20232022/Q438.781M / 33.521M--
--2022/Q365.977M / 43.876M--
Aug 2, 20222022/Q236.547M / 37.613M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 5, 2024

Buy

  • Buy

    66.67%
  • Hold

    16.67%
  • Sell

    16.67%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg